Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation ... s PulseSelect PFA device was approved ...
In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...
Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation (AFib) in the United States, as it ...
Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation (AFib ... Medtronic’s PulseSelect PFA device was ...
From smart rings that can detect atrial fibrillation to cutlery that can help you cut back on sodium intake, these are the best wellness innovations we found at CES to help you live better.
The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.
About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...